RR-171
RR-171 is an amino acid polypeptide and an inhibitor of the Wnt signaling pathway. RR-171 reduces the expression levels of Wnt-1, GSK3β and β-catenin. RR-171 induces apoptosis (Apoptosis) in pancreatic cancer cells, which is characterized by an increased Bax/Bcl-2 ratio, activation of Caspase-3/7/9, and increased Cleaved-PARP; this pro-apoptotic effect can be partially reversed by Z-VAD-FMK (HY-16658B). RR-171 also induces pyroptosis (Pyroptosis) in pancreatic cancer cells, which is manifested by activation of the NLRP-3 inflammasome, activation of Caspase-1, cleavage of GSDMD, upregulation of IL-1β and IL-18, and increased LDH release; this pro-pyroptotic effect can be partially reversed by VX-765 (HY-13205). RR-171 inhibits the viability, proliferation and colony formation of pancreatic cancer cells, with low cytotoxicity against normal cells. RR-171 downregulates the expression of Ki-67 and PCNA in tumor tissues in vivo, with favorable biosafety. RR-171 can be used in studies related to pancreatic cancer.
For research use only. We do not sell to patients.
- CAS No.: 2410535-57-6
- Formula: C92H177N41O18
- Molecular Weight:2145.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Caspase-1 |
Caspase-3 |
Caspase-9 |
Caspase-7 |
IL-1β |
IL-18 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Capan-2 | IC50 |
24.70 μM
|
Inhibition of cell viability against human Capan-2 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
Inhibition of cell viability against human Capan-2 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
|
40229415 |
| BXPC-3 | IC50 |
15.71 μM
|
Inhibition of cell viability against human Bxpc-3 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
Inhibition of cell viability against human Bxpc-3 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
|
40229415 |
| PANC-1 | IC50 |
75.68 μM
|
Inhibition of cell viability against human Panc-1 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
Inhibition of cell viability against human Panc-1 pancreatic cancer cells incubated for 24 hrs by CCK-8 assay.
|
40229415 |
In Vitro
RR-171 (0-200 µM; 24 h) inhibits the viability of Panc-1, Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner, with IC50 values of 75.68 µM, 24.70 µM and 15.71 µM, respectively; whereas it exerts weak inhibitory effects on HPNE normal pancreatic epithelial cells (IC50 = 144.50 µM)[1].
RR-171 (0-20 µM; 24 h) inhibits colony formation of Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner[1].
RR-171 (0-20 µM; 48 h) inhibits the proliferation of Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner[1].
RR-171 (0-20 µM; 24 h) reduces the expression of Wnt-1, GSK3β and β-catenin in Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner, thereby inhibiting the canonical Wnt signaling pathway[1].
RR-171 (0-20 µM; 24 h) regulates the expression of apoptosis-related proteins in Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner; it increases the levels of Bax and cleaved PARP, while decreasing the levels of Bcl-2, caspase-3, caspase-7 and caspase-9[1].
Treatment of Capan-2 pancreatic cancer cells with RR-171 (20 µM; 24 h) alters their global gene expression, thereby enriching apoptosis-related pathways and inhibiting the canonical Wnt signaling pathway[1].
RR-171 (0-20 µM; 24 h) induces caspase-mediated apoptosis in Capan-2 and Bxpc-3 pancreatic cancer cells in a dose-dependent manner, and this effect is partially reversed by Z-VAD-FMK (HY-16658B)[1].
Treatment of Capan-2 pancreatic cancer cells with RR-171 (5-20 µM; 24 h) induces dose-dependent morphological changes consistent with pyroptosis, including reduced cell junctions, membrane blebbing and cell rupture[1].
RR-171 (0-20 µM; 24 h) induces dose-dependent LDH release in Capan-2 and Bxpc-3 pancreatic cancer cells. This effect is significantly reversed by the pyroptosis inhibitor VX-765, but cannot be completely reversed by the pan-caspase inhibitor Z-VAD-FMK[1].
RR-171 (0-20 µM; 24 h) dose-dependently upregulates the expression of pyroptosis-related proteins (NLRP-3, GSDMD, caspase-1, IL-1β, IL-18) in Capan-2 and Bxpc-3 pancreatic cancer cells, and this effect is reversed by VX-765 (HY-13205)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Panc-1, Capan-2, Bxpc-3, HPNE
-
Concentration:0, 0.5, 1, 5, 10, 20, 40, 80, 100 and 200 µM
-
Incubation Time:24 h
-
Result:Inhibited pancreatic cancer cell viability in a dose-dependent manner, with reduced inhibitory effects on normal pancreatic epithelial cells.
Achieved IC50 values of 24.70 µM for Capan-2 cells, 15.71 µM for Bxpc-3 cells, 5075.68 µM for Panc-1 cells, and 144.50 µM for HPNE cells at 24 h.
-
Cell Line:Capan-2, Bxpc-3
-
Concentration:5, 10 and 20 µM
-
Incubation Time:48 h
-
Result:Distinctly suppressed the proliferation of Capan-2 and Bxpc-3 cells in a dose-dependent manner, as indicated by reduced EdU-positive staining relative to control cells.
-
Cell Line:Capan-2, Bxpc-3
-
Concentration:5, 10 and 20 µM
-
Incubation Time:24 h
-
Result:Decreased the expression levels of Wnt-1, GSK3β, and β-catenin in a dose-dependent manner in both Capan-2 and Bxpc-3 cells, confirming inhibition of the canonical Wnt signaling pathway.\nDecreased antiapoptotic protein Bcl-2 expression, while increased proapoptotic protein Bax expression in a dose-dependent manner as concentration increased.
Reduced levels of caspase-3, caspase-7, and caspase-9, while increased cleaved-PARP levels, indicating activation of the caspase-mediated apoptosis pathway.
-
Cell Line:Capan-2, Bxpc-3
-
Concentration:5, 10 and 20 µM
-
Incubation Time:24 h
-
Result:Distinctively increased the percentage of apoptotic Capan-2 and Bxpc-3 cells in a dose-dependent manner.
Significantly reduced the apoptosis ratio in both cell lines when co-treated with Z-VAD-FMK, confirming a caspase-dependent mechanism.
-
Cell Line:Capan-2, Bxpc-3
-
Concentration:5, 10 and 20 µM
-
Incubation Time:24 h
-
Result:Increased levels of NLRP-3, GSDMD, caspase-1, IL-1β, and IL-18 in a dose-dependent manner in both cell lines.
Decreased the elevated levels of these pyroptosis-related proteins when co-treated with VX-765.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (female, 5-6 weeks old, subcutaneous pancreatic cancer xenograft model)[1]
-
Dosage:20 mg/kg
-
Administration:i.p.; every 3 days; three weeks
-
Result:Reduced tumor volume significantly starting on Day 17 post-cell injection.
Lowered final tumor weight significantly compared to controls.
Showed no significant difference in mouse body weight between groups.
Decreased average density of Ki-67 and PCNA in tumor tissues significantly.
Exhibited no significant organ toxicity in lung, heart, liver, spleen, and kidney tissues.
Chemical Information
-
CAS No. 2410535-57-6
-
Molecular Weight 2145.65
-
Formula C92H177N41O18
-
Sequence
Arg-Arg-Arg-Arg-Leu-Val-Ala-Gly-Val-Leu-Val-Leu-Leu-Arg-Arg-Arg-Arg
-
Sequence Shortening
RRRRLVAGVLVLLRRRR
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Ki-67 Immunostaining Proliferation Assay
Ki-67 immunostaining measures the growth fraction of a cell population by detecting Ki-67, a nuclear antigen present in proliferating cells and absent in quiescent G0 cells. The readout is the percentage of Ki-67-positive nuclei among total counted cells, commonly called the Ki-67 labeling index or proliferation index.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
PCNA Immunodetection Proliferation Assay
PCNA immunodetection measures proliferative activity by detecting proliferating cell nuclear antigen, a nuclear protein associated with DNA polymerase δ function and DNA replication. The assay readout is the proportion of PCNA-positive nuclei among total counted cells, but PCNA labeling is not identical to BrdU labeling because PCNA can mark late G1/early S-associated replication competence and may persist beyond active DNA synthesis depending on fixation and extraction conditions.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)